Synergy of gemcitabine and lidamycin associated with NF-κB downregulation in pancreatic carcinoma cells

Acta Pharmacologica Sinica

Volumn 29, Issue 5, 2008, Pages 614-619

  Chen, Jing ^a,b   Wu, Shu Ying ^a   Ou Yang, Zhi Gang ^a   Zhen, Yong Su ^a  

^a INSTITUTE OF MEDICINAL BIOTECHNOLOGY   (China)

^b NORTH CHINA COAL MEDICAL COLLEGE   (China)

Author keywords

Combination; Drug therapy; Gemcitabine; K ras; Lidamycin; NF B; Pancreatic cancer

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANTIBIOTIC C 1027; CASPASE 3; GEMCITABINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; K RAS PROTEIN; LIDAMYCIN; MESSENGER RNA; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG POTENTIATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; NICK END LABELING; PANCREAS CARCINOMA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 42649141625     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2008.00774.x     Document Type: Article

References (21)

1. 1 Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, et al. Cancer statistics. Cancer J Clin 2006 ; 56: 106–30.
2. 2 Abbruzzese JL. New application of gemcitabine and future directions in the management of pancreatic cancer. Cancer 2002 ; 95: 941–5.
3. 3 Dziegielewski J, Beerman TA. Cellular responses to the DNA strand‐scission enediyne C‐1027 can be independent of ATM, ATR, and DNA‐PK kinases. J Biol Chem 2002 ; 277: 20549–54.
4. 4 Hu JL, Xue YC, Xie MY, Zhang R, Otani T, Minami Y, et al. A new macromolecular antitumor antibiotic, C‐1027. I. Discovery, taxonomy of producing organism, fermentation and biological activity. J Antibiot 1988 ; 41: 1575–9.
5. 5 Otani T, Minami Y, Marunaka T, Zhang R, Xie MY. A new macromolecular antitumor antibiotic, C‐1027. II. Isolation and physico‐chemical properties. J Antibiot 1988 ; 41: 1580–5.
6. 6 Sakata N, Ikeno S, Hori M, Hamada M, Otani T. Cloning and nucleotide sequencing of the antitumor antibiotic C‐1027 apoprotein gene. Biosci Biotechnol Biochem 1992 ; 56: 1592–5.
7. 7 Tanaka T, Hirama M, Otani T. Solution structures of C‐1027 apoprotein and its complex with the aromatized chromophore. J Mol Biol 2001 ; 309: 267–83.
8. 8 Zhen YS, Ming XY, Yu B, Otani T, Saito H, Yamada Y. A new macromolecular antitumor antibiotic, C‐1027. III. Antitumor activity. J Antibiot 1989 ; 42: 1294–8.
9. 9 Xu YJ, Zhen YS, Goldberg IH. C‐1027 chromophore, a potent new enediyne antitumor antibiotic, induces sequence‐specific double‐strand DNA cleavage. Biochemistry 1994 ; 33: 5947–54.
10. 10 Zhen HY, Xue YC, Zhen YS. Inhibition of angiogenesis by antitumor antibiotic C‐1027 and its effect on tumor metastasis. Natl Med J China 1997 ; 77: 657–60.
11. 11 Huang YH, Shang BY, Zhen YS. Antitumor efficacy of lidamycin on hepatoma and active moiety of its molecule. World J Gastroenterol 2005 ; 11: 3980–4.
12. 12 Chen J, Ou‐Yang ZG, Zhang SH, Zhen YS. Down‐regulation of NF‐κB by lidamycin in association with inducing apoptosis in human pancreatic cancer cells and inhibiting xenograft growth. Oncol Rep 2007 ; 17: 1445–51.
13. 13 Almoguera C, Shibata D, Forrester K, Martin J, Arnheim N, Perucho M. Most human carcinomas of the exocrine pancreas contain mutant c‐K‐ ras gene. Cell 1988 ; 53: 549–54.
14. 14 Osada M, Tolkacheva T, Li W, Chan TO, Tsichlis PN, Saez R, et al. Differential roles of Akt, Rac, and Ral in R‐Ras‐mediated cellular transformation, adhesion, and survival. Mol Cell Biol 1999 ; 19: 6333–44.
15. 15 Arlt A, Gehrz A, Muerkoster S, Vorndamm J, Kruse ML, Folsch UR, et al. Role of NF‐κB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine‐induced cell death. Oncogene 2003 ; 22: 3243–51.
16. 16 Mohammad RM, Banerjee S, Li Y, Aboukameel A, Kucuk O, Sarkar FH. Cisplatin‐induced antitumor activity is potentiated by the soy isoflavone genistein in BxPC‐3 pancreatic tumor xenografts. Cancer 2006 ; 106: 1260–8.
17. 17 Yip‐Schneider MT, Nakshatri H, Sweeney CJ, Marshall MS, Wiebke EA, Schmidt CM. Parthenolide and sulindac cooperate to mediate growth suppression and inhibit the nuclear factor‐kappa B pathway in pancreatic carcinoma cells. Mol Cancer Ther 2005 ; 4: 587–94.
18. 18 Foster KA, Galeffi F, Gerich FJ, Turner DA, Muller M. Optical and pharmacological tools to investigate the role of mitochondria during oxidative stress and neurodegeneration. Prog Neurobiol 2006 ; 79: 136–71.
19. 19 Lovric J, Cho SJ, Winnik FM, Maysinqeret D. Unmodified cadmium telluride quantum dots induce reactive oxygen species formation leading to multiple organelle damage and cell death. Chem Biol 2005 ; 12: 1227–34.
20. 20 Kluck RM, Bossy‐Wetzel E, Green DR, Newmeyer DD. The release of cytochrome c from mitochondria: a primary site for bcl‐2 regulation of apoptosis. Science 1997 ; 275: 1132–6.
21. 21 Cheng EH, Wei MC, Weiler S, Flavell RA, Mak TW, Lindsten T, et al. Bcl‐2, Bcl‐x1 sequester BH3 domain‐only molecules preventing Bax‐ and Bak‐mediated mitochondrial apoptosis. Mol Cell 2001 ; 8: 705–11.